Search This Blog

Thursday, December 13, 2018

Millendo Therapeutics initiated at Leerink


Millendo Therapeutics initiated with an Outperform at Leerink. Leerink analyst Joseph Schwartz started Millendo Therapeutics with an Outperform rating and $24 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)